Severe maternal morbidity and mortality from amniotic fluid embolism in the Netherlands

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 8, 2012, Pages 991-995

  Stolk, Koen H ^a   Zwart, Joost J ^a,b   Schutte, Joke ^c   Van Roosmalen, Jos ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GROENE HART HOSPITAL   (Netherlands)

^c ISALA HOSPITAL   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amniotic fluid embolism; gynecology; maternal mortality; obstetrics; severe maternal morbidity; the Netherlands

Indexed keywords

ADULT; AMNION FLUID EMBOLISM; ARTICLE; CESAREAN SECTION; DYSPNEA; FEMALE; HUMAN; INCIDENCE; LABOR INDUCTION; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MULTIPARA; NETHERLANDS; OBSTETRIC HEMORRHAGE; PERINATAL MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; CESAREAN SECTION; EMBOLISM, AMNIOTIC FLUID; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; LABOR, INDUCED; MATERNAL AGE; MATERNAL MORTALITY; MORBIDITY; NETHERLANDS; ODDS RATIO; PARITY; PREGNANCY; REGISTRIES; RISK FACTORS;

EID: 84863897905     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01442.x     Document Type: Article

References (19)

1. Meyer JR,. Embolia-pulmonar amnio caseosa. Brasil-med. 1926; 2: 301.
2. Steiner PE, Lushbaugh CC,. Maternal pulmonary embolism by amniotic fluid. J Am Med Assoc. 1941; 117: 1245.
3. Marcus B, Collins K, Harley R,. Ancillary studies in amniotic fluid embolism: a case report and review of the literature. Am J Forensic Med Pathol. 2005; 26: 92-5. (Pubitemid 40289279)
4. Benson M, Kobayashi H, Silver R,. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol. 2001; 97: 510-4.
5. Fineschi V, Riezzo I,. Complement C3a expression and tryptase degranulation as promising histopathological tests for diagnosing fatal amniotic fluid embolism. Virchows Arch. 2009; 454: 283-91.
6. Raper R, Fisher M,. Profound reversible myocardial depression after anaphylaxis. Lancet. 1988; 331: 386-8. (Pubitemid 18046996)
7. Parrillo J,. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993; 328: 1471-7.
8. Schutte JM, Steegers EA, Schuitemaker NW, Santema JG, de Boer K, Pel M, et al,. Rise in maternal mortality in the Netherlands. Br J Obstet Gynaecol. 2010; 117: 397-406.
9. Zwart J, Richters JM, Öry F, de Vries JIP, Bloemenkamp KWM, van Roosmalen J,. Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population-based study of 371 000 pregnancies. Br J Obstet Gynaecol. 2008; 115: 842-50. (Pubitemid 351692992)
10. Benson M,. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypoth. 2007; 68: 1019-24.
11. The Netherlands Perinatal Registry. Perinatale Zorg in Nederland. Zutphen: Tesink, 2005.
12. The Netherlands Perinatal Registry. Perinatale Zorg in Nederland. Zutphen: Tesink, 2006.
13. The Netherlands Perinatal Registry. Perinatale Zorg in Nederland. Zutphen: Tesink, 2007.
14. The Netherlands Perinatal Registry. Perinatale Zorg in Nederland. Zutphen: Tesink, 2008.
15. Schuitemaker N, Van Roosmalen J, Dekker G,. Confidential enquiry into maternal deaths in The Netherlands 1983-1992. Eur J Obstet Gynecol Reprod Biol. 1998; 79: 57-62. (Pubitemid 28234426)
16. Schutte JM,. Rise in maternal mortality in the Netherlands. Br J Obstet Gynaecol. 2010; 117: 399-406.
17. Abenhaim H, Azoulay L, Kramer M, Leduc L,. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol. 2008; 199: 49e1-8.
18. Lewis G,. The Confidential Enquiry into Maternal and Child Health (CEMACH), Saving Mothers' Lives, 2003-2005. The seventh report of confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH, 2007.
19. Knight M,. Incidence and Risk Factors for Amniotic-Fluid Embolism. Obstet Gynecol. 2010; 115: 910-7.